Literature DB >> 2572541

The selective antigen-presenting cell capacity of activated B lymphocytes in HLA-II-restricted responses of CD4+ T lymphocytes.

T T Van Der Pouw Kraan1, F E Stiekema, M B Teunissen, J D Bos, L Kapsenberg.   

Abstract

We examined the role of antigen-presenting B lymphocytes using panels of antigen-specific CD4+8-T-lymphocyte clones (TLC). All 19 TLC showed a class II major histocompatibility complex-encoded (HLA-II) restricted proliferation to antigen presented by antigen-presenting cells (APC) from the monocyte fraction of peripheral blood. Only six TLC were effectively activated by antigen presented by autologous B lymphocytes activated by EBV transformation. This failure of B lymphocytes was not due to: (i) a high degree of cell surface sialic acid; (ii) a low expression of the cell surface proteins HLA-II, ICAM-1 or LFA-3 that restrict antigen presentation; (iii) lack of secretion of the cytokine IL-1 or other soluble factors that may be required as secondary signals; or (iv) induction of incomplete T-cell activation resulting in the production of growth factor interleukin-2 (IL-2) or the expression of receptors for IL-2 only. These data suggest the involvement of another cell surface interaction in antigen presentation acting besides the interactions known so far.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2572541      PMCID: PMC1385408     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  39 in total

1.  Assay of the infectivity of Epstein-Barr virus by transformation of human leucocytes in vitro.

Authors:  D J Moss; J H Pope
Journal:  J Gen Virol       Date:  1972-11       Impact factor: 3.891

2.  Monoclonal antibody to a novel lymphocyte function-associated antigen (LFA-1): mechanism of blockade of T lymphocyte-mediated killing and effects on other T and B lymphocyte functions.

Authors:  D Davignon; E Martz; T Reynolds; K Kürzinger; T A Springer
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

Review 3.  Dendritic cells: features and functions.

Authors:  R M Steinman; M C Nussenzweig
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

4.  Characterization of major histocompatibility antigens on trinitrophenyl-modified cells.

Authors:  L T Clement; E M Shevach
Journal:  Mol Immunol       Date:  1979-01       Impact factor: 4.407

5.  Relationship between trinitrophenyl and H-2 antigens on trinitrophenyl-modified spleen cells. I. H-2 antigens on cells treated with trinitrobenzene sulfonic acid are derivatized.

Authors:  J Forman; E S Vitetta; D A Hart; J Klein
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

6.  Studies on the capacity of B cells to serve as antigen-presenting cells.

Authors:  R W Chesnut; H M Grey
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

7.  Macrophage-dependent response of immune human T lymphocytes to PPD in vitro. Influence of HLA-D histocompatibility.

Authors:  B O Bergholtz; E Thorsby
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

Review 8.  A hypothesis to relate the specificity of T lymphocytes and the activity of I region-specific Ir genes in macrophages and B lymphocytes.

Authors:  B Benacerraf
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

9.  Ia antigen-bearing B cell tumor lines can present protein antigen and alloantigen in a major histocompatibility complex-restricted fashion to antigen-reactive T cells.

Authors:  L H Glimcher; K J Kim; I Green; W E Paul
Journal:  J Exp Med       Date:  1982-02-01       Impact factor: 14.307

10.  Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes.

Authors:  A S Rosenthal; E M Shevach
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

View more
  1 in total

1.  Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis.

Authors:  H Löhr; M Manns; A Kyriatsoulis; A W Lohse; C Trautwein; K H Meyer zum Büschenfelde; B Fleischer
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.